Retour
Prix NewGenIvf Group Ltd (NIVF)
Graphique du cours de l'action NIVF
NIVF Gagner
NewGenIvf Group Ltd
$0.76
3.89%
$0.02
À partir d'aujourd'hui :Feb 13, 14:32:22 GMT-5
Pas encore de donnéesEarnings FAQ
Comment le bénéfice par action récent de NIVF se compare-t-il aux attentes ?
Comment les revenus de NewGenIvf Group Ltd NIVF se sont-ils comportés au dernier trimestre ?
Quelle est l'estimation des revenus pour NewGenIvf Group Ltd ?
Quel est le score de qualité des bénéfices pour NewGenIvf Group Ltd ?
Quand NewGenIvf Group Ltd publie-t-elle ses résultats ?
Quels sont les bénéfices attendus de NewGenIvf Group Ltd ?
NewGenIvf Group Ltd a-t-elle dépassé les attentes en matière de bénéfices ?
Statistiques clés
Clôture préc.
$0.7315
Prix d'ouverture
$0.805
Plage de la journée
$0.7501 - $0.8185
Plage de 52 semaines
$0.6901 - $2,165.25
Volume
113.5K
Volume moyen
664.3K
BPA (TTM)
104.69
Rendement en dividend
--
Capitalisation boursière
$1.0M
Qu’est-ce que NIVF ?
NewGenIvf Group Ltd is a TH-based company operating in Health Care Providers & Services industry. The company is headquartered in Bangkok, Bangkok Metropolis and currently employs 76 full-time employees. The company went IPO on 2022-02-15. NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. The company specializes in in-vitro fertilization (IVF) treatment and surrogacy and ancillary caring services. Its fertility treatments, such as IVF, intracytoplasmic sperm injection, intrauterine insemination, egg freezing, embryo transfer, gender selection, semen analysis, hysteroscopy, fertility checkups, testicular sperm aspiration and percutaneous epididymal sperm aspiration. Its clinics are in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. The company has acquired cytometry technology and assets including 18 fully constructed cell-sorting and dispensing systems, eight partially constructed units and six patents related to advanced microfluidic systems.
Fonctionnalités
Ressources
© 2026 Finture Development Limited. Tous droits réservés.